Navigation Links
Osiris in Medical News

Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.

NEW YORK, April 13 /PRNewswire-FirstCall/ -- A top biotech executive, William Pursley, has agreed to become Chairman of Rx for Africa, Inc.'s (Pink Sheets: RXAF) newly created Business Advisory Board. For 25 years Mr. Pursley has held major executive positions in the biotech industry. In 1985 he j...

JDRF Partners with Osiris to evaluate an immunomodulatory cell therapy product for type 1 diabetes

JDRF Partners with Osiris on a Phase II Trial to Evaluate an Immunomodulatory Cell Therapy Product For Type 1 Diabetes New York, NY October 25, 2007 The Juvenile Diabetes Research Foundation announced today a partnership with Osiris Therapeutics, Inc. (NASDAQ:OSIR) to support a Phase II cli...

Biotech Osiris to go public

Baltimore biotech, the company that is known for being the sole manufacturer of the stem cell product, has made its plans known, about its intention to go public//. The company is slated to sell out nearly $80 million in shares, as per the papers filed with the Securities and Exchange Commission. ...

Long Term Supply of Osteocel(R) Plus Solidified Without Ownership of Processing Facility

...Vasive has accelerated the transfer of the processing of Osteocel Plus from osiris Therapeutics (Nasdaq: OSIR ) to its own exclusive supply chain. Sin...and consistent stream of supply. NuVasive will not assume ownership of the osiris tissue processing facility. NuVasive reiterates its previous guidance ...

Ongoing worldwide shortage of medical isotopes could threaten patient care, says expert

...ld's Mo-99 is produced by five commercial nuclear reactors NRU at Chalk River in Canada, HFR at Petten in The Netherland, BR-2 at Fleurus in Belgium, osiris at Saclay in France and SAFARI-1 at Pelindaba in South Africa. The UK has no facility for producing Mo-99 of its own. Until fairly recently, productio...

BullMarket.com Examines Stem Cell Stocks

...ibers with coverage of stem cell stocks, including Geron (Nasdaq: GERN ), osiris Therapeutics (Nasdaq: OSIR ), Cytori Therapeutics (Nasdaq: CYTX ), and ...ptions surrounding stem cell stocks? -- What are some of the positives osiris has going for it? -- What potential problem could Cytori run into? ...

NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results

...nge of $345 million to $350 million. Osteocel revenue in the fourth quarter 2008 included approximately $5 million in sales to former distributors of osiris Therapeutics, Inc. (Nasdaq: OSIR ). As the Company launches the Osteocel product through its exclusive sales force, it will not have the benefit of...

QRxPharma Expands Management Team with the Addition of Dr. Jesus Soriano as Executive Vice President

...o joining QRxPharma, Soriano was Senior Director of Business Development at osiris Therapeutics, Inc., and responsible for all business development activities... out-licensing and divestiture. During Dr. Soriano's tenure, Maryland-based osiris Therapeutics formed a $1.4 billion partnership with Genzyme Corp. for the d...

Stem Cell Product Commercialization Focus of Summit

...Inc. Novocell, Inc. ArunA Biomedical, Inc. NuVasive, Inc. BioE Corp. osiris Therapeutics, Inc. California Stem Cell, Inc. Progenitor Cell Therapy, Inc. Cellerix, S.A. SpineSmit...

Preliminary Lineup Set for 4th Annual Stem Cell Summit

... Arteriocyte, Inc. Novocell, Inc. BioE Corp. NuVasive, Inc. California Stem Cell, Inc. osiris Therapeutics, Inc. Cellerix, S.A. Progenitor Cell Therapy, Inc. Cognate BioServices, Inc. Stemagen Cytori Ther...
Osiris in Medical Technology

Pain Relief in Just One Visit with Genzyme's Synvisc-One

...ceuticals, Genzyme Biosurgery, Integra LifeSciences, LifeNet Health, Medtronic Spinal and Biologics, Musculoskeletal Transplant Foundation, Orthovita, osiris Therapeutics, Osteotech, RTI Biologics, sanofi-aventis, Smith & Nephew, Stryker, Synthes, Wright Medical Technology, and many more. Other reports ...

Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function

...dical Center, we were able to conduct a study that was exceptionally well planned and executed” said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. “We were confident in the safety profile given our previous experience using the intravenous form of these stem cells to treat oth...
Osiris in Medical Products

Osiris

Description:... osiris is a system built around data management software and an imaging device that measures the inhibition zone size around an antibiotic disc. osiris offers built-in expertise for detection of potential errors and detection o...
Company:Bio-Rad Laboratories
Osiris in Biological News

Stem cell therapy shows promise in regenerating damaged muscle in heart attack patients

...em cells pre-formulated for intravenous delivery by the drug's manufacture, osiris Therapeutics. Patients were administered an infusion of either Provacel or...well planned and executed" said C. Randal Mills Ph.D., President and CEO of osiris Therapeutics. "We were confident in the safety profile given our previous e...
Osiris in Biological Technology

NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics

- Expands biologics platform for robust growth - - Includes proprietary adult stem cell bone graft product and processing facility - - Expects Osteocel(R) revenues of $15 million in 2008 and $25 million in 2009; no dilution to earnings per share in...

NeoStem Featured in Business Week; 'Promising' Adult Stem Cell Market Discussed in Fortune-CNNMoney.com Article

...tal Partners, a Pan-Asian private equity firm with deep connections across Asia, declared, "I believe investors are beginning to see that, compared to osiris -- which is the largest stem cell company with a market cap of around $425 million -- NBS is dramatically undervalued given its IP portfolio, product ...

AssureRx Adds New CEO

... the buyout of a New York Stock Exchange company to form MedPointe Pharmaceuticals. Mr. Burns was also a founder, chairman, president and CEO of osiris Therapeutics Inc., a public biotech company developing therapeutic stem-cell products for the regeneration of damaged or diseased tissues. Previously,...

Heart Hospital of Austin First Site in World to Test Efficacy of New Adult Stem Cell Therapy to Treat Damaged Heart Tissue in Phase II Trial

...o or animal. MSCs have the ability to develop into other types of cells and generate new tissue, including heart muscle. Prochymal(R) is a product of osiris Therapeutics, Inc. "There's a lot of enthusiasm in the cardiovascular community about the potential of stem cell therapies for treating heart dis...

Three Firms, Two Training Programs Garner Greater Baltimore Committee's 2009 Bioscience Awards

... Best New Product or Progress: C. Randal Mills, Ph.D., president and CEO, osiris Therapeutics, Inc. Mills' Columbia-based company has spent more than $300 million developing stem cell therapies. The funding has allowed osiris to complete clinical trials necessary to demonstrate the safety and efficac...

Greater Baltimore Committee to Announce Winners of 2009 Maryland Bioscience Awards at Ceremonies on March 12

...agement Corporation Fred E. Festa , chairman, president and CEO, W.R. Grace & Company Dr. C. Randal Mills , president and CEO, osiris Therapeutics, Inc. Dr. Bruce Thompson , chairman of the board and president, Clinical Trials and Surveys Corp. (C-TASC) Lea...

NuVasive Completes Acquisition of Osteocel Biologics Business

... surgical treatments for the spine, announced today that it has completed the previously announced acquisition of the Osteocel biologics business from osiris Therapeutics, Inc. (Nasdaq: OSIR ) for $35 million in cash, plus additional milestone-based contingent payments not to exceed $50 million in either c...

BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals

... biologists, chemists and many others attended to interview with some of the top biotechnology companies and pharmaceutical firms. Companies including osiris Therapeutics and SAIC-Frederick were hiring for biotech business development careers, pharmaceutical facility management jobs, cell biology careers, b...

Stem Cell Therapy to Skyrocket by 2017

...dvanced Cell Technologies, Arteriocyte, Blackstone Medical, Cytori Therapeutics, Geron, Harvest Technologies, International Stem Cell Corporation, and osiris Therapeutics. About Stem Cells Stem cells are primal cells that are derived from highly proliferative tissues. These cells are precursors to every o...
Other Tags
(Date:7/31/2015)... ... July 31, 2015 , ... The 2nd annual Ride to ... Downtown Memphis on October 3, 2015. The Ride to Fight On is a cycling ... between Methodist Healthcare, The West Clinic and The University of Tennessee Health Science Center. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin and ... their social media profiles to better connect with the public. The agency website ... information, share insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide ...
(Date:7/31/2015)... , ... July 31, 2015 , ... According to the article published July ... the Pasadena courthouse was contained and extinguished by the city’s fire department before it caused ... building at the time of the fire, and it was a fire alarm system that ...
(Date:7/31/2015)... ... July 31, 2015 , ... Cosmetic Town has ... alike on various plastic surgery procedures including, but not limited to, abdominoplasty, blepharoplasty, ... procedures like Botox and fillers. , Staying up to date with the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the most modern ... of a visionary image that goes beyond the boundaries of fertility medicine. , ... reached extraordinary heights with dependable patient support, affordable treatments, unending hope, and high fertility ...
Breaking Medicine News(10 mins):Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ... Generation Biometrics Market by Application, Technology, Function & Geography ... offering. The next generation biometrics market is ... CAGR of 17.9% between 2015 and 2020 ... market. Safran SA ( France ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting ... the addition of two new team members. ... David Raviv will act as head of strategic ... to providing the most secure solutions for the enterprise market. ... 7 Technologies, a provider of security and management products, which ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
Other Contents